Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada

References

• Ahamad, K., Milloy, M. J., Nguyen, P., Uhlmann, S., Johnson, C., Korthuis, T. P., Kerr, T., & Wood, E. (2015). Factors associated with willingness to take extended release naltrexone among injection drug users. Addiction Science & Clinical Practice, 10(1), 12. https://doi.org/10.1186/s13722-015-0034-5
   PubMedGoogle Scholar
• Akinsemolu, A., Ogston, S., & Irvine, L. (2011). P2-354 Effectiveness of opioid substitution therapy among prisoners with drug dependence: A meta analysis. Journal of Epidemiology & Community Health, 65(Suppl 1), A320–A. https://doi.org/10.1136/jech.2011.142976k.86
   Google Scholar
• Andraka-Christou, B., Randall-Kosich, O., & Totaram, R. (2020). Designing an “ideal” substance use disorder treatment center: Perspectives of people who have utilized medications for opioid use disorder. Qualitative Health Research, 31(3), 512–17. https://doi.org/10.1177/1049732320971231
   Web of Science ®Google Scholar
• Bahji, A., Carlone, D., & Altomare, J. (2020). Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: A systematic review and meta‐analysis. Addiction, 115(8), 1413–1425. https://doi.org/10.1111/add.14946
   PubMed Web of Science ®Google Scholar
• Banta-Green, C. J., Floyd, A. S., Vick, K., Arthur, J., Hoeft, T. J., & Tsui, J. I. (2019). Opioid use disorder treatment decision making and care navigation upon release from prison: A feasibility study. Substance Abuse and Rehabilitation, 10, 57–67. https://doi.org/10.2147/SAR.S192045
   PubMed Web of Science ®Google Scholar
• Beaudette, J. (2013). Prevalence of mental health disorders among incoming federal offenders. Research Branch, Correctional Service Canada.
   Google Scholar
• Bellamy, C., Kimmel, J., Costa, M. N., Tsai, J., Nulton, L., Nulton, E., Kimmel, A., Aguilar, N. J., Clayton, A., & O’Connell, M. (2019). Peer support on the “inside and outside”: Building lives and reducing recidivism for people with mental illness returning from jail. Journal of Public Mental Health. 18(3), 188–198. https://doi.org/10.1108/JPMH-02-2019-0028
   Web of Science ®Google Scholar
• Binswanger, I. A., Stern, M., Deyo, R., Heagerty, P., Cheadle, A., Elmore, J., & Koepsell, T. D. (2007). Release from prison: A high risk of death for former inmates. New England Journal of Medicine, 356(2), 157–165. https://doi.org/10.1056/NEJMsa064115
   PubMed Web of Science ®Google Scholar
• Binswanger, I. A., Nowels, C., Corsi, K. F., Long, J., Booth, R. E., Kutner, J., & Steiner, J. F. (2011). “From the prison door right to the sidewalk, everything went downhill,” a qualitative study of the health experiences of recently released inmates. International Journal of Law and Psychiatry, 34(4), 249–255. https://doi.org/10.1016/j.ijlp.2011.07.002
   PubMed Web of Science ®Google Scholar
• Binswanger, I. A., Nowels, C., Corsi, K. F., Glanz, J., Long, J., Booth, R. E., & Steiner, J. F. (2012). Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors. Addiction Science & Clinical Practice, 7(3), 1–9. https://doi.org/10.1186/1940-0640-7-3
   Google Scholar
• Bozinoff, N., DeBeck, K., Milloy, M. J., Nosova, E., Fairbairn, N., Wood, E., & Hayashi, K. (2018). Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada. Drug and Alcohol Dependence, 193, 42–47. https://doi.org/10.1016/j.drugalcdep.2018.09.003
   Web of Science ®Google Scholar
• Brinkley-Rubinstein, L., Cloud, D. H., Davis, C., Zaller, N., Delany-Brumsey, A., Pope, L., Martino, S., Bouvier, B., & Rich, J. (2017). Addressing excess risk of overdose among recently incarcerated people in the USA: Harm reduction interventions in correctional settings. International Journal of Prisoner Health, 13(1), 25–31. https://doi.org/10.1108/IJPH-08-2016-0039
   PubMed Web of Science ®Google Scholar
• Brinkley-Rubinstein, L., Zaller, N., Martino, S., Cloud, D. H., McCauley, E., Heise, A., & Seal, D. (2018). Criminal justice continuum for opioid users at risk of overdose. Addictive Behaviors, 86, 104–110. https://doi.org/10.1016/j.addbeh.2018.02.024
   PubMed Web of Science ®Google Scholar
• Brinkley-Rubinstein, L., Cloud, D., Drucker, E., & Zaller, N. (2018). Opioid use among those who have criminal justice experience: Harm reduction strategies to Lessen HIV Risk. Current HIV/AIDS Reports, 15(3), 255–258. https://doi.org/10.1007/s11904-018-0394-z
   Web of Science ®Google Scholar
• The British Columbia Centre on Substance Use (BCCSU). (2017). A guideline for the clinical management of opioid use disorder.
   Google Scholar
• Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E. (2018). Management of opioid use disorders: A national clinical practice guideline. Canadian Medical Association Journal, 190(9), E247–E57. https://doi.org/10.1503/cmaj.170958
   PubMed Web of Science ®Google Scholar
• Bunting, A. M., Oser, C. B., Staton, M., Eddens, K. S., & Knudsen, H. (2018). Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: A social ecological approach. Addiction Science & Clinical Practice, 13(1), 23. https://doi.org/10.1186/s13722-018-0124-2
   PubMedGoogle Scholar
• Caulkins, J. P., Gould, A., Pardo, B., Reuter, P., & Stein, B. D. (2021). Opioids and the criminal justice system: New challenges posed by the modern opioid epidemic. Annual Review of Criminology, 4(1), 353–375. https://doi.org/10.1146/annurev-criminol-061020-125715
   Google Scholar
• Chamberlain, A., Nyamu, S., Aminawung, J., Wang, E. A., Shavit, S., & Fox, A. D. (2019). Illicit substance use after release from prison among formerly incarcerated primary care patients: A cross-sectional study. Addiction Science & Clinical Practice, 14(1), 1–8. https://doi.org/10.1186/s13722-019-0136-6
   PubMedGoogle Scholar
• Chappuy, M., Meroueh, F., Trojak, B., Bachellier, J., Bendimerad, P., Kosim, M., Hjelmström, P., Nubukpo, P., Brousse, G., & Rolland, B. (2021). Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder. Patient Preference and Adherence, 15, 1259–1267. https://doi.org/10.2147/PPA.S311674
   PubMed Web of Science ®Google Scholar
• Compton, W. M., & Volkow, N. D. (2021). Extended-release buprenorphine and its evaluation with patient-reported outcomes. JAMA Network Open, 4(5), e219708–e. https://doi.org/10.1001/jamanetworkopen.2021.9708
   PubMed Web of Science ®Google Scholar
• Correctional Service Canada. (2007). Protecting society through community corrections.
   Google Scholar
• Correctional Service Canada. (2013). The offender management system.
   Google Scholar
• Correctional Service Canada. (2019). Opioids.
   Google Scholar
• Correctional Service Canada. (2020). Guidance on opioid agoinst treatment (OAT).
   Google Scholar
• Correctional Service Canada. (2021). Opioid agonist treatment.
   Google Scholar
• Creswell, J. W., & Creswell, J. D. (2017). Research design: Qualitative, quantitative, and mixed methods approaches. Sage publications.
   Google Scholar
• Cropsey, K. L., Villalobos, G. C., & St Clair, C. L. (2005). Pharmacotherapy treatment in substance-dependent correctional populations: A review. Substance Use & Misuse, 40(13–14), 1983–99, 2043–8. https://doi.org/10.1080/10826080500294866
   Web of Science ®Google Scholar
• Crowley, D., & Van Hout, M. C. (2017). Effectiveness of pharmacotherapies in increasing treatment retention and reducing opioid overdose death in individuals recently released from prison: A systematic review. Heroin Addiction and Related Clinical Problems, 19(2), 1592–1638. https://researchonline.ljmu.ac.uk/id/eprint/7648
   Web of Science ®Google Scholar
• Eisenstein, L. G., Fisher, J., Simon, L., & Tobey, M. (2020). Challenges and Opportunities for Patients Released from Correctional Facilities: A Qualitative Analysis. Journal of General Internal Medicine, 35(4), 1328–1329. https://doi.org/10.1007/s11606-019-05216-y
   Web of Science ®Google Scholar
• Farrell-Macdonald, S., MacSwain, M.-A., Cheverie, M., Tiesmaki, M., & Fischer, B. (2014). Impact of methadone maintenance treatment on women offenders. Post-Release Recidivism. European Addiction Research, 20(4), 192–199. https://doi.org/10.1159/000357942
   PubMed Web of Science ®Google Scholar
• Fazel, S., Hayes, A. J., Bartellas, K., Clerici, M., & Trestman, R. (2016). Mental health of prisoners: Prevalence, adverse outcomes, and interventions. The Lancet Psychiatry, 3(9), 871–881. https://doi.org/10.1016/S2215-0366(16)30142-0
   PubMed Web of Science ®Google Scholar
• Fazel, S., Yoon, I. A., & Hayes, A. J. (2017). Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction, 112(10), 1725–1739. https://doi.org/10.1111/add.13877
   PubMed Web of Science ®Google Scholar
• Fox, A. D., Maradiaga, J., Weiss, L., Sanchez, J., Starrels, J. L., & Cunningham, C. O. (2015). Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder. Addiction Science & Clinical Practice, 10(1), 2. https://doi.org/10.1186/s13722-014-0023-0
   PubMed Web of Science ®Google Scholar
• Fox, A. D., Jakubowski, A. U., & Giftos, J. (2019). Enhancing treatment access and effectiveness: Toward patient-centered models of care. Springer.
   Google Scholar
• Fox, A. D., Moore, A., & Kinner, S. (2019). Deaths in custody and following release. Journal of Health and Human Services Administration, 41(4), 45–84.
   Google Scholar
• Fusch, P. I., & Ness, L. R. (2015). Are we there yet? Data saturation in qualitative research. The Qualitative Report, 20(9), 14008. https://www.jstor.org/stable/26974609
   Google Scholar
• Gisev, N., Bharat, C., Larney, S., Dobbins, T., Weatherburn, D., Hickman, M., Farrell, M., & Degenhardt, L. (2019). The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: A retrospective cohort study. The Lancet Public Health, 4(7), e334–e42. https://doi.org/10.1016/S2468-2667(19)30060-X
   Web of Science ®Google Scholar
• Glanville, J. M., Perry, A. E., James, M. M.-S., Hewitt, C., Swami, S., Wright, K., Burns, L., Pearson, C., Aboaja, A., Thakkar, P., Kumar, K. M. S., & Bunney, M. (2021). Pharmacological interventions for drug-using offenders: An update to a systematic review and meta-analysis. Journal of Experimental Criminology. https://doi.org/10.1007/s11292-020-09453-8
   Google Scholar
• Gordon, M. S., Vocci, F. J., Fitzgerald, T. T., O’Grady, K. E., & O’Brien, C. P. (2017). Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. Contemporary Clinical Trials, 53, 130–136. https://doi.org/10.1016/j.cct.2016.12.015
   PubMed Web of Science ®Google Scholar
• Gordon, M. S., Vocci, F. J., Taxman, F., Fishman, M., Sharma, B., Blue, T. R., & O’Grady, K. E. (2019). A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment. Contemporary Clinical Trials, 79, 21–27. https://doi.org/10.1016/j.cct.2019.02.009
   Web of Science ®Google Scholar
• Grella, C. E., Ostile, E., Scott, C. K., Dennis, M., & Carnavale, J. (2020). A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. International Journal of Drug Policy, 81, 102768. https://doi.org/10.1016/j.drugpo.2020.102768
   PubMed Web of Science ®Google Scholar
• Grella, C. E., Ostlie, E., Scott, C. K., Dennis, M. L., Carnevale, J., & Watson, D. P. (2021). A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Substance abuse treatment, prevention, and policy. 16(1), 1–39. https://doi.org/10.1186/s13011-021-00346-1
   Web of Science ®Google Scholar
• Groot, E., Kouyoumdjian, F. G., Kiefer, L., Madadi, P., Gross, J., Prevost, B., Jhirad, R., Huyer, D., Snowdon, V., & Persaud, N. (2016). Drug toxicity deaths after release from incarceration in ontario, 2006-2013: Review of Coroner’s cases. PloS One, 11(7), e0157512. https://doi.org/10.1371/journal.pone.0157512
   Web of Science ®Google Scholar
• Hall, G., Neighbors, C. J., Iheoma, J., Dauber, S., Adams, M., Culleton, R., Muench, F., Borys, S., McDonald, R., & Morgenstern, J. (2014). Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals. Journal of Substance Abuse Treatment, 46(4), 511–515. https://doi.org/10.1016/j.jsat.2013.11.002
   PubMed Web of Science ®Google Scholar
• Hall, W., & Farrell, M. (2018). Prisoners and risk of injury after release. The Lancet Public Health, 3(5), e209–e10. https://doi.org/10.1016/S2468-2667(18)30073-2
   Web of Science ®Google Scholar
• Hard, B. (2021). Increased treatment engagement and adherence: Flexible management with prolonged-release buprenorphine in treatment of opioid dependence. Case Reports in Psychiatry, 2021, 6657350. https://doi.org/10.1155/2021/6657350
   Google Scholar
• Health Canada. (2019). Regulatory decision summary - sublocade.
   Google Scholar
• Hedrich, D., Alves, P., Farrell, M., Stöver, H., Møller, L., & Mayet, S. (2012). The effectiveness of opioid maintenance treatment in prison settings: A systematic review. Addiction, 107(3), 501–517. https://doi.org/10.1111/j.1360-0443.2011.03676.x
   PubMed Web of Science ®Google Scholar
• Hopkin, G., Evans-Lacko, S., Forrester, A., Shaw, J., & Thornicroft, G. (2018). Interventions at the transition from prison to the community for prisoners with mental illness: A systematic review. Administration and Policy in Mental Health and Mental Health Services Research, 45(4), 623–634. https://doi.org/10.1007/s10488-018-0848-z
   PubMed Web of Science ®Google Scholar
• Howell, B. A., Puglisi, L., Clark, K., Albizu-Garcia, C., Ashkin, E., Booth, T., Brinkley-Rubinstein, L., Fiellin, D. A., Fox, A. D., Maurer, K. F., Lin, H.-J., McCollister, K., Murphy, S., Morse, D. S., Shavit, S., Wang, K., Winkelman, T., & Wang, E. A. (2021). The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. Journal of Substance Abuse Treatment, 128, 108315. https://doi.org/10.1016/j.jsat.2021.108315
   Web of Science ®Google Scholar
• Hu, C., Jurgutis, J., Edwards, D., O’Shea, T., Regenstreif, L., Bodkin, C., Amster, E., & Kouyoumdjian, F. G. (2020). “When you first walk out the gateswhere do [you] go?”: Barriers and opportunities to achieving continuity of health care at the time of release from a provincial jail in Ontario. PloS One, 15(4), e0231211. https://doi.org/10.1371/journal.pone.0231211
   PubMed Web of Science ®Google Scholar
• Jackson, J. (2021). “They talk to me like a person” Experiences of people with opioid use disorder in an injectable opioid agonist treatment (iOAT) program: A qualitative interview study using interpretive description. Qeios. https://doi.org/10.32388/8981E5
   Google Scholar
• Jamin, D., Vanderplasschen, W., Sys, O., Jauffret-Roustide, M., Michel, L., Trouiller, P., Neisa, A., Homen, M., Mendes, V., & Stöver, H. (2021). “My first 48 hours out”: Drug users’ perspectives on challenges and strategies upon release from prison. Harm Reduction Journal, 18(1), 32. https://doi.org/10.1186/s12954-021-00480-w
   Web of Science ®Google Scholar
• Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019). A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice, 14(1), 17. https://doi.org/10.1186/s13722-019-0145-5
   PubMedGoogle Scholar
• Keen, C., Young, J. T., Borschmann, R., & Kinner, S. A. (2020). Non-fatal drug overdose after release from prison: A prospective data linkage study. Drug and Alcohol Dependence, 206, 107707. https://doi.org/10.1016/j.drugalcdep.2019.107707
   Web of Science ®Google Scholar
• Kelly, L., & Farrell Macdonald, S. (2015a). Comparing lifetime substance use patterns of men and women offenders. Correctional Service Canada.
   Google Scholar
• Kelly, L., & Farrell Macdonald, S. (2015b). Lifetime substance use patterns of men offenders. Correctional Service Canada.
   Google Scholar
• Kendall, S., Redshaw, S., Ward, S., Wayland, S., & Sullivan, E. (2018). Systematic review of qualitative evaluations of reentry programs addressing problematic drug use and mental health disorders amongst people transitioning from prison to communities. Health & Justice, 6(1), 4. https://doi.org/10.1186/s40352-018-0063-8
   PubMedGoogle Scholar
• Kirwan, A., Curtis, M., Dietze, P., Aitken, C., Woods, E., Walker, S., Kinner, S., Ogloff, J., Butler, T., & Stoové, M. (2019). The Prison and Transition Health (PATH) cohort study: Study protocol and baseline characteristics of a cohort of men with a history of injecting drug use leaving prison in Australia. Journal of Urban Health, 96(3), 400–410. https://doi.org/10.1007/s11524-019-00353-5
   PubMed Web of Science ®Google Scholar
• Korownyk, C., Perry, D., Ton, J., Kolber, M. R., Garrison, S., Thomas, B., Allan, G. M., Bateman, C., de Queiroz, R., Kennedy, D., Lamba, W., Marlinga, J., Mogus, T., Nickonchuk, T., Orrantia, E., Reich, K., Wong, N., Dugré, N., & Lindblad, A. J. (2019). Managing opioid use disorder in primary care: PEER simplified guideline. Canadian Family Physician Medecin de Famille Canadien, 65(5), 321–330. https://www.cfp.ca/content/65/5/321
   PubMed Web of Science ®Google Scholar
• Kouyoumdjian, F. G., Calzavara, L. M., Kiefer, L., Main, C., & Bondy, S. (2014). Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada. Canadian Journal of Public Health, 105(3), e198–202. https://doi.org/10.17269/cjph.105.4193
   PubMed Web of Science ®Google Scholar
• Kouyoumdjian, F. G., Schuler, A., Matheson, F. I., & Hwang, S. W. (2016). Health status of prisoners in Canada. Canadian Family Physician Medecin de Famille Canadien, 62(3), 215–222. https://pubmed.ncbi.nlm.nih.gov/27427562/
   PubMed Web of Science ®Google Scholar
• Kouyoumdjian, F. G., Kiefer, L., Wobeser, W., Gonzalez, A., & Hwang, S. W. (2016). Mortality over 12 years of follow-up in people admitted to provincial custody in Ontario: A retrospective cohort study. CMAJ Open, 4(2), E153–61. https://doi.org/10.9778/cmajo.20150098
   Google Scholar
• Kouyoumdjian, F. G., Cheng, S. Y., Fung, K., Humphreys-Mahaffey, S., Orkin, A. M., Kendall, C., Kiefer, L., Matheson, F. I., Green, S. E., & Hwang, S. W. (2018). Primary care utilization in people who experience imprisonment in Ontario, Canada: A retrospective cohort study. BMC Health Services Research, 18(1), 845. https://doi.org/10.1186/s12913-018-3660-2
   Google Scholar
• Kouyoumdjian, F. G., Patel, A., To, M. J., Kiefer, L., Regenstreif, L., & Perry, A. (2018). Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey. PloS One, 13(2), e0192431. https://doi.org/10.1371/journal.pone.0192431
   Web of Science ®Google Scholar
• Kouyoumdjian, F. G., & Orkin, A. M. (2020). Improving health and healthcare access for people who experience imprisonment in Ontario. Healthcare Quarterly (Toronto, Ont), 23(1), 6–9. https://doi.org/10.12927/hcq.2020.26146
   Google Scholar
• Krawczyk, N., Buresh, M., Gordon, M. S., Blue, T. R., Fingerhood, M. I., & Agus, D. (2019). Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap. Journal of Substance Abuse Treatment, 103, 1–8. https://doi.org/10.1016/j.jsat.2019.05.002
   PubMed Web of Science ®Google Scholar
• Krsak, M., Montague, B. T., Trowbridge, P., Johnson, S. C., & Binswanger, I. A. (2020). Opioid use and chronic infections: The value of addressing the syndemic in correctional settings via telemedicine guidance and broader use of long-acting medications. The Journal of Infectious Diseases, 222(Suppl._5), S486–S93. https://doi.org/10.1093/infdis/jiaa001
   Google Scholar
• Larney, S., & Dolan, K. (2009). A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care? European Addiction Research, 15(2), 107–112. https://doi.org/10.1159/000199046
   PubMed Web of Science ®Google Scholar
• Larney, S., Zador, D., Sindicich, N., & Dolan, K. (2017). A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia. Drug and Alcohol Review, 36(3), 305–310. https://doi.org/10.1111/dar.12442
   PubMed Web of Science ®Google Scholar
• Lintzeris, N., Dunlop, A. J., Haber, P. S., Lubman, D. I., Graham, R., Hutchinson, S., Arunogiri, S., Hayes, V., Hjelmström, P., Svedberg, A., Peterson, S., & Tiberg, F. (2021). Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: A randomized clinical trial. JAMA Network Open, 4(5), e219041–e. https://doi.org/10.1001/jamanetworkopen.2021.9041
   PubMed Web of Science ®Google Scholar
• Macmadu, A., & Rich, J. D. (2015). Correctional health is community health. Issues in Science and Technology, 32(1), 26–36. http://myaccess.library.utoronto.ca/login?qurl=https%3A%2F%2Fwww.proquest.com%2Fscholarly-journals%2Fcorrectional-health-is-community%2Fdocview%2F1774763701%2Fse-2%3Faccountid%3D14771
   Web of Science ®Google Scholar
• MacSwain, M. A., Farrell Macdonald, S., Cheverie, M., & Fischer, B. (2013). Assessing the impact of methadone maintenance treatment (MMT) on post-release recidivism among male federal correctional inmates in Canada. Criminal Justice and Behavior, 41(3), 380–394. https://doi.org/10.1177/0093854813501495
   Web of Science ®Google Scholar
• Madadi, P., Hildebrandt, D., Lauwers, A. E., Koren, G., & Eldabe, S. (2013). Characteristics of opioid-users whose death was related to opioid-toxicity: A population-based study in Ontario, Canada. PLoS One, 8(4), e60600. https://doi.org/10.1371/journal.pone.0060600
   PubMed Web of Science ®Google Scholar
• Maina, G., Tahir, H., Docabo, A., Kahia, N., & Brunelle, C. (2019). Exploring health-care providers’ experiences in the care of clients on opioid agonist treatment in two western Canadian clinics. Canadian Journal of Nursing Research, 52(1), 15–24. https://doi.org/10.1177/0844562119842751
   PubMed Web of Science ®Google Scholar
• Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., Fischer, B., & Tsai, A. C. (2019). Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLOS Medicine, 16(12), e1003002. https://doi.org/10.1371/journal.pmed.1003002
   PubMed Web of Science ®Google Scholar
• Maradiaga, J. A., Nahvi, S., Cunningham, C. O., Sanchez, J., & Fox, A. D. (2016). “I kicked the hard way. I got incarcerated.” Withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. Journal of Substance Abuse Treatment, 62, 49–54. https://doi.org/10.1016/j.jsat.2015.11.004
   PubMed Web of Science ®Google Scholar
• Marchand, K., Beaumont, S., Westfall, J., MacDonald, S., Harrison, S., Marsh, D. C., Schechter, M. T., & Oviedo-Joekes, E. (2018). Patient-centred care for addiction treatment: A scoping review protocol. BMJ Open, 8(12), e024588. https://doi.org/10.1136/bmjopen-2018-024588
   PubMed Web of Science ®Google Scholar
• Martin, R. A., Gresko, S. A., Brinkley-Rubinstein, L., Stein, L. A. R., & Clarke, J. G. (2019). Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program. Preventive Medicine, 128, 105766. https://doi.org/10.1016/j.ypmed.2019.105766
   PubMed Web of Science ®Google Scholar
• McKenzie, M., Nunn, A., Zaller, N. D., Bazazi, A. R., & Rich, J. D. (2009). Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice. Journal of Opioid Management, 5(4), 219–227. https://doi.org/10.5055/jom.2009.0024
   PubMedGoogle Scholar
• McLeod, K. E., & Martin, R. E. (2018). Health in correctional facilities is health in our communities. Canadian Medical Association Journal, 190(10), E274–E5. https://doi.org/10.1503/cmaj.171357
   PubMed Web of Science ®Google Scholar
• MedicaSafe. (2019). Developing Effective Medication Regimens: National Institute on Drug Abuse (NIDA). Available from: https://www.medicasafe.com/
   Google Scholar
• Moore, K. E., Roberts, W., Reid, H. H., Smith, K. M. Z., Oberleitner, L. M. S., & McKee, S. A. (2019). Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review. Journal of Substance Abuse Treatment, 99, 32–43. https://doi.org/10.1016/j.jsat.2018.12.003
   PubMed Web of Science ®Google Scholar
• Mullins, P., & Farrell, S. (2012). Offender substance use patterns-aboriginal and non-aboriginal offenders: Research branch. Correctional Service Canada.
   Google Scholar
• Murphy, Y., Ali, F., & Fischer, B. (2018). Health and service access challenges for correctional offenders with mental health and substance use problems in transition from incarceration to community: A literature review. Ottawa, Ontario.
   Google Scholar
• Murphy, Y., & Sapers, H. (2020). Prison health as public health in Ontario corrections. Journal of Community Safety and Well-Being, 5(1), 19–25. https://doi.org/10.35502/jcswb.122
   Google Scholar
• Myers, J. J., Dufour, M.-S. K., Koester, K. A., Morewitz, M., Packard, R., Klein, K. M., Estes, M., Williams, B., Riker, A., & Tulsky, J. (2018). The effect of patient navigation on the likelihood of engagement in clinical care for HIV-infected individuals leaving jail. American Journal of Public Health, 108(3), 385–392. https://doi.org/10.2105/AJPH.2017.304250
   PubMed Web of Science ®Google Scholar
• Nunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009). Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug and Alcohol Dependence, 105(1–2), 83–88. https://doi.org/10.1016/j.drugalcdep.2009.06.015
   PubMed Web of Science ®Google Scholar
• O’Connor, C., & Joffe, H. (2020). Intercoder reliability in qualitative research: Debates and practical guidelines. International Journal of Qualitative Methods, 19, 1609406919899220. https://doi.org/10.1177/1609406919899220
   Web of Science ®Google Scholar
• O’Gurek, D. T., Jatres, J., Gibbs, J., Latham, I., Udegbe, B., & Reeves, K. (2021). Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting. Journal of Substance Abuse Treatment, 127, 108342. https://doi.org/10.1016/j.jsat.2021.108342
   PubMed Web of Science ®Google Scholar
• Office of the Correctional Investigator. (2014). Overcoming Barriers to Reintegration: An investigation of federal community correctional centres: Final report.
   Google Scholar
• Ontario Ministry of Children CaSSM. (2021). Ontario disability support program (ODSP) income support directives: Incarceration. Ontario Ministry of Children, Comunity and Social Services (MCCS).
   Google Scholar
• Owens, M. D., Chen, J. A., Simpson, T. L., Timko, C., & Williams, E. C. (2018). Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Addiction Science & Clinical Practice, 13(1), 19. https://doi.org/10.1186/s13722-018-0120-6
   PubMedGoogle Scholar
• Perry, A. E., Neilson, M., James, M.-S., Glanville, J. M., Woodhouse, R., Godfrey, C., and Hewitt, Catherine, et al. (2015). Pharmacological interventions for drug-using offenders. Cochrane Database of Systematic Reviews. 6. http://doi.org/10.1002/14651858.CD010862.pub2
   Google Scholar
• Ray, B., Watson, D. P., Xu, H., Salyers, M. P., Victor, G., Sightes, E., Bailey, K., Taylor, L. R., & Bo, N. (2021). Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT. Journal of Substance Abuse Treatment, 126, 108339. https://doi.org/10.1016/j.jsat.2021.108339
   PubMed Web of Science ®Google Scholar
• Russell, C., Nafeh, F., Pang, M., Farrell Macdonald, S., Derkzen, D., Rehm, J., and Fischer , Benedikt et al. (2021). Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: A mixed-methods study. BMC Public Health. 22(1), 1–19. https://link.springer.com/article/10.1186/s12889-022-12685-0
   Web of Science ®Google Scholar
• Russolillo, A., Moniruzzaman, A., McCandless, L. C., Patterson, M., & Somers, J. M. (2018). Associations between methadone maintenance treatment and crime: A 17-year longitudinal cohort study of Canadian provincial offenders. Addiction, 113(4), 656–667. https://doi.org/10.1111/add.14059
   PubMed Web of Science ®Google Scholar
• Russolillo, A., Moniruzzaman, A., Somers, J. M., & Hall, W. D. (2018). Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada. PLoS Medicine, 15(7), e1002625. https://doi.org/10.1371/journal.pmed.1002625
   PubMed Web of Science ®Google Scholar
• Saunders, B., Sim, J., Kingstone, T., Baker, S., Waterfield, J., Bartlam, B., Burroughs, H., & Jinks, C. (2018). Saturation in qualitative research: Exploring its conceptualization and operationalization. Quality & Quantity, 52(4), 1893–1907. https://doi.org/10.1007/s11135-017-0574-8
   PubMed Web of Science ®Google Scholar
• Schwartz, R. P., Mitchell, M. M., O’Grady, K. E., Kelly, S. M., Gryczynski, J., Mitchell, S. G., Gordon, M. S., & Jaffe, J. H. (2018). Pharmacotherapy for opioid addiction in community corrections. International Review of Psychiatry, 30(5), 117–135. https://doi.org/10.1080/09540261.2018.1524373
   PubMed Web of Science ®Google Scholar
• Sharma, A., O’Grady, K. E., Kelly, S. M., Gryczynski, J., Mitchell, S. G., & Schwartz, R. P. (2016). Pharmacotherapy for opioid dependence in jails and prisons: Research review update and future directions. Substance Abuse and Rehabilitation, 7, 27–40. https://doi.org/10.2147/SAR.S81602
   PubMed Web of Science ®Google Scholar
• Shavit, S., Aminawung, J. A., Birnbaum, N., Greenberg, S., Berthold, T., Fishman, A., Busch, S. H., & Wang, E. A. (2017). Transitions clinic network: Challenges and lessons in primary care for people released from prison. Health Affairs, 36(6), 1006–1015. https://doi.org/10.1377/hlthaff.2017.0089
   Web of Science ®Google Scholar
• Special Advisory Committee on the Epidemic of Opioid Overdoses. (2020). National report: Opioid related harms in Canada. Government of Canada and Public Health Agency of Canada
   Google Scholar
• Stallwitz, A., & Stover, H. (2007). The impact of substitution treatment in prisons - A literature review. International Journal of Drug Policy, 18(6), 464–474. https://doi.org/10.1016/j.drugpo.2006.11.015
   PubMed Web of Science ®Google Scholar
• Stewart, R. E., Shen, L., Kwon, N., Vigderman, J., Kramer, S., Mandell, D. S., Candon, M., Lamb, R., & Rothbard, A. B. (2021). Transporting to treatment: Evaluating the effectiveness of a mobile engagement unit. Journal of Substance Abuse Treatment, 129, 108377. https://doi.org/10.1016/j.jsat.2021.108377
   Web of Science ®Google Scholar
• Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009). Opioid dependence treatment: Options in pharmacotherapy. Expert Opinion on Pharmacotherapy, 10(11), 1727–1740. https://doi.org/10.1517/14656560903037168
   PubMed Web of Science ®Google Scholar
• Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020). Opioid use disorder. Nature Reviews. Disease Primers, 6(1), 3. https://doi.org/10.1038/s41572-019-0137-5
   PubMed Web of Science ®Google Scholar
• Thomas, K., Wilson, J. L., Bedell, P., & Morse, D. S. (2019). “They didn’t give up on me”: A women’s transitions clinic from the perspective of re-entering women. Addiction Science & Clinical Practice, 14(1), 12. https://doi.org/10.1186/s13722-019-0142-8
   Google Scholar
• Vail, W., Faro, E., Watnick, D., Giftos, J., & Fox, A. D. (2021). Does incarceration influence patients’ goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail. Drug and Alcohol Dependence, 222, 108529. https://doi.org/10.1016/j.drugalcdep.2021.108529
   PubMed Web of Science ®Google Scholar
• Velasquez, M., Flannery, M., Badolato, R., Vittitow, A., McDonald, R. D., Tofighi, B., Garment, A. R., Giftos, J., & Lee, J. D. (2019). Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addiction Science & Clinical Practice, 14(1), 37. https://doi.org/10.1186/s13722-019-0166-0
   PubMed Web of Science ®Google Scholar
• Vorspan, F., Hjelmström, P., Simon, N., Benyamina, A., Dervaux, A., Brousse, G., Jamain, T., Kosim, M., & Rolland, B. (2019). What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine. Expert Opinion on Drug Delivery, 16(9), 907–914. https://doi.org/10.1080/17425247.2019.1649252
   PubMed Web of Science ®Google Scholar
• Wachino, V., & Artiga, S. (2019). How connecting justice-involved individuals to Medicaid can help address the opioid epidemic. Kaiser Family Foundation. https://files.kff.org/attachment/Issue-Brief-How-Connecting-Justice-Involved-Individuals-to-Medicaid-can-Help-Address-the-Opioid-Epidemic
   Google Scholar
• Waddell, E. N., Baker, R., Hartung, D. M., Hildebran, C. J., Nguyen, T., Collins, D. R. M., Larsen, J. E., Stack, E., Bialas, T., Bielavitz, S., Gregg, J., Korthuis, P. T., Kunkel, L., Lee, J. D., Leichtling, G., Meyer, D. L., Nichols, C., & Wiest, K. (2020). Reducing overdose after release from incarceration (ROAR): Study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. Health & Justice, 8(1), 18. https://doi.org/10.1186/s40352-020-00113-7
   PubMedGoogle Scholar
• Waddell, E. N., Springer, S. A., Marsch, L. A., Farabee, D., Schwartz, R. P., Nyaku, A., Reeves, R., Goldfeld, K., McDonald, R. D., Malone, M., Cheng, A., Saunders, E. C., Monico, L., Gryczynski, J., Bell, K., Harding, K., Violette, S., Groblewski, T., Martin, W., … Lee, J. D. (2021). Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). Journal of Substance Abuse Treatment, 128, 108389. https://doi.org/10.1016/j.jsat.2021.108389
   Web of Science ®Google Scholar
• Watson, D. P., Ray, B., Robison, L., Xu, H., Edwards, R., Salyers, M. P., Hill, J., & Shue, S. (2017). Developing Substance Use Programming for Person-Oriented Recovery and Treatment (SUPPORT): Protocol for a pilot randomized controlled trial. Pilot and Feasibility Studies, 3(1), 73. https://doi.org/10.1186/s40814-017-0212-1
   Google Scholar
• Western, B., & Simes, J. T. (2019). Drug use in the year after prison. Social Science & Medicine, 235, 112357. https://doi.org/10.1016/j.socscimed.2019.112357
   Web of Science ®Google Scholar
• Williams, M., & Moser, T. (2019). The art of coding and thematic exploration in qualitative research. International Management Review, 15(1), 45–55. http://www.imrjournal.org/uploads/1/4/2/8/14286482/imr-v15n1art4.pdf
   Google Scholar
• Winkelman, T. N. A., Chang, V. W., & Binswanger, I. A. H. (2018). Polysubstance Use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558–e. https://doi.org/10.1001/jamanetworkopen.2018.0558
   PubMed Web of Science ®Google Scholar
• Winter, R. J., Young, J. T., Stoové, M., Agius, P. A., Hellard, M. E., & Kinner, S. A. (2016). Resumption of injecting drug use following release from prison in Australia. Drug and Alcohol Dependence, 168, 104–111. https://doi.org/10.1016/j.drugalcdep.2016.08.640
   PubMed Web of Science ®Google Scholar
• Yatsco, A. J., Champagne-Langabeer, T., Holder, T. F., Stotts, A. L., & Langabeer, J. R. (2020). Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives. International Journal of Drug Policy, 83, 102849. https://doi.org/10.1016/j.drugpo.2020.102849
   Web of Science ®Google Scholar